News4 min read
mRNA Melanoma Vaccine Cuts Recurrence Risk 42% in Trial
Merck and Moderna's personalized mRNA therapy, intismeran, cut melanoma recurrence or death by 42% in a Phase 3 trial. What the data show and what's next.
Topic
#Health
2 stories tagged Health.
Lifestyle5 min read
Toothpaste Recall 2026: Brush Buddies, Evo and ARU Tubes
More than 4.3 million tubes of Brush Buddies, Evo and ARU toothpaste are in an FDA Class II recall. The full product list and what to do if you have one.
Browse sections
- News5 storiesBreaking and trending U.S. news, explained without the noise.
- Tech5 storiesGadgets, AI, apps and the tech stories everyone is searching for.
- Entertainment5 storiesMovies, TV, music, streaming and celebrity news trending in the U.S.
- Sports5 storiesNFL, NBA, MLB, college sports and the moments fans are talking about.
- Money5 storiesPersonal finance, markets, jobs and the economy, in plain English.
- Lifestyle5 storiesHealth, food, travel, home and the trends shaping everyday American life.